| Ligand | Protein Symbol | Approved Name | Docking Scores |
Similarity Score |
Best Match | ||
|---|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | |||||
| Etoricoxib | 5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -8.98 | -9.35 | -10.00 | 36.67% | CHEMBL2419440 |
| Indomethacin | 5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -8.95 | -9.22 | -8.65 | 62.86% | CHEMBL263700 |
| Etoricoxib | 5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -8.86 | -8.83 | N/A | 38.26% | CHEMBL91463 |
| Indomethacin | 5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -9.01 | -8.20 | N/A | 53.79% | CHEMBL267615 |
| Etoricoxib | 5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -8.74 | -9.35 | -8.46 | 46.86% | CHEMBL3099899 |
| Indomethacin | 5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -9.03 | -8.92 | -9.29 | 49.69% | CHEMBL221811 |
| Etoricoxib | 5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -8.84 | -10.37 | N/A | 38.26% | CHEMBL91463 |
| Indomethacin | 5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -9.36 | -8.53 | N/A | 59.49% | CHEMBL2260565 |
| Etoricoxib | AA1R_HUMAN | adenosine A1 receptor | -9.64 | -9.37 | -8.70 | 47.22% | CHEMBL223828 |
| Indomethacin | AA1R_HUMAN | adenosine A1 receptor | -9.21 | -8.81 | -9.96 | 50.67% | CHEMBL2435536 |
| Etoricoxib | AA2AR_HUMAN | adenosine A2a receptor | -9.61 | -9.73 | -9.96 | 54.36% | CHEMBL448781 |
| Indomethacin | AA2AR_HUMAN | adenosine A2a receptor | -9.37 | -9.57 | -9.92 | 42.86% | CHEMBL3677906 |
| Etoricoxib | ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -9.79 | -9.72 | -10.41 | 39.26% | CHEMBL3582228 |
| Indomethacin | ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -9.64 | -10.23 | -9.76 | 54.07% | CHEMBL4102333 |
| Etoricoxib | ACE_HUMAN | angiotensin I converting enzyme | -8.57 | -8.67 | -6.72 | 29.08% | CHEMBL191 |
| Indomethacin | ACE_HUMAN | angiotensin I converting enzyme | -8.44 | -8.58 | -7.49 | 46.11% | CHEMBL305388 |
| Etoricoxib | ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -7.11 | N/A | N/A | 20.81% | CHEMBL386114 |
| Indomethacin | ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -7.17 | N/A | N/A | 33.80% | CHEMBL386114 |
| Etoricoxib | ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | -5.15 | -6.81 | -6.60 | N/A | N/A |
| Indomethacin | ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | -4.17 | -2.49 | -2.93 | N/A | N/A |
| Etoricoxib | ACM1_HUMAN | cholinergic receptor muscarinic 1 | -9.45 | -3.41 | N/A | 36.09% | CHEMBL3600828 |
| Indomethacin | ACM1_HUMAN | cholinergic receptor muscarinic 1 | -7.97 | 1.86 | N/A | 50.00% | CHEMBL3126661 |
| Etoricoxib | ACM4_HUMAN | cholinergic receptor muscarinic 4 | -9.52 | -8.73 | N/A | 32.24% | CHEMBL40391 |
| Indomethacin | ACM4_HUMAN | cholinergic receptor muscarinic 4 | -8.68 | -9.94 | N/A | 43.75% | CHEMBL104332 |
| Etoricoxib | ADRB2_HUMAN | adrenoceptor beta 2 | -9.43 | -8.48 | -9.72 | 42.14% | CHEMBL1483308 |
| Indomethacin | ADRB2_HUMAN | adrenoceptor beta 2 | -8.76 | -9.08 | -8.71 | 49.69% | CHEMBL444553 |
| Etoricoxib | AGTR2_HUMAN | angiotensin II receptor type 2 | -9.91 | -8.98 | -9.96 | 33.87% | CHEMBL1017 |
| Indomethacin | AGTR2_HUMAN | angiotensin II receptor type 2 | -8.79 | -9.13 | -8.95 | 49.25% | CHEMBL40381 |
| Etoricoxib | ALDR_HUMAN | aldo-keto reductase family 1 member B | -8.86 | -9.39 | -8.80 | 32.20% | CHEMBL1917446 |
| Indomethacin | ALDR_HUMAN | aldo-keto reductase family 1 member B | -8.98 | -8.72 | -8.53 | 48.50% | CHEMBL1944855 |
| Etoricoxib | AMPN_HUMAN | alanyl aminopeptidase, membrane | -9.06 | -9.81 | -8.43 | 22.67% | CHEMBL1077591 |
| Indomethacin | AMPN_HUMAN | alanyl aminopeptidase, membrane | -8.25 | -9.08 | -8.48 | 44.66% | CHEMBL1077591 |
| Etoricoxib | AOFA_HUMAN | monoamine oxidase A | -9.21 | -9.94 | -10.14 | 49.26% | CHEMBL3652429 |
| Indomethacin | AOFA_HUMAN | monoamine oxidase A | -9.57 | -10.12 | -10.14 | 46.01% | CHEMBL155350 |
| Etoricoxib | AOFB_HUMAN | monoamine oxidase B | -10.19 | -9.50 | -9.39 | 42.45% | CHEMBL3398531 |
| Indomethacin | AOFB_HUMAN | monoamine oxidase B | -9.99 | -10.20 | -10.17 | 42.08% | CHEMBL2333929 |
| Etoricoxib | BACE1_HUMAN | beta-secretase 1 | -7.96 | -7.89 | -8.87 | 41.30% | CHEMBL1923751 |
| Indomethacin | BACE1_HUMAN | beta-secretase 1 | -7.31 | -7.70 | -9.12 | 42.36% | CHEMBL556087 |
| Etoricoxib | CAH2_HUMAN | carbonic anhydrase 2 | -8.02 | -9.08 | -7.39 | 50.43% | CHEMBL3763387 |
| Indomethacin | CAH2_HUMAN | carbonic anhydrase 2 | -7.55 | -8.64 | -8.92 | 49.69% | CHEMBL2335176 |
| Etoricoxib | CASP1_HUMAN | caspase 1 | -6.11 | -7.50 | -6.69 | 33.33% | CHEMBL269599 |
| Indomethacin | CASP1_HUMAN | caspase 1 | -6.27 | -6.91 | -6.82 | 50.60% | CHEMBL1221644 |
| Etoricoxib | CDK5_HUMAN | cyclin dependent kinase 5 | -7.96 | -8.69 | -7.04 | 40.82% | CHEMBL1972988 |
| Indomethacin | CDK5_HUMAN | cyclin dependent kinase 5 | -8.26 | -9.52 | -9.53 | 48.52% | CHEMBL1970352 |
| Etoricoxib | CHLE_HUMAN | butyrylcholinesterase | -9.50 | -9.12 | -9.01 | 42.74% | CHEMBL3954861 |
| Indomethacin | CHLE_HUMAN | butyrylcholinesterase | -9.17 | -9.33 | -9.45 | 51.85% | CHEMBL3628186 |
| Etoricoxib | CNR1_HUMAN | cannabinoid receptor 1 | -7.92 | -10.30 | -10.40 | 54.48% | CHEMBL247103 |
| Indomethacin | CNR1_HUMAN | cannabinoid receptor 1 | -7.56 | -9.31 | -10.10 | 56.76% | CHEMBL2206858 |
| Etoricoxib | CNR2_HUMAN | cannabinoid receptor 2 | -9.79 | -9.85 | N/A | 47.13% | CHEMBL577986 |
| Indomethacin | CNR2_HUMAN | cannabinoid receptor 2 | -9.23 | -9.20 | N/A | 92.70% | CHEMBL72324 |
| Etoricoxib | COLI_HUMAN | proopiomelanocortin | -9.10 | -8.92 | -8.54 | N/A | N/A |
| Indomethacin | COLI_HUMAN | proopiomelanocortin | -8.57 | -8.55 | -8.17 | N/A | N/A |
| Etoricoxib | COMT_HUMAN | catechol-O-methyltransferase | -6.75 | -6.36 | -6.20 | 34.69% | CHEMBL3798286 |
| Indomethacin | COMT_HUMAN | catechol-O-methyltransferase | -6.23 | -6.16 | -7.30 | 40.72% | CHEMBL3425731 |
| Etoricoxib | CRP_HUMAN | C-reactive protein | -6.56 | -6.52 | N/A | N/A | N/A |
| Indomethacin | CRP_HUMAN | C-reactive protein | -6.41 | -5.84 | N/A | N/A | N/A |
| Etoricoxib | CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | -3.52 | N/A | N/A | 24.61% | CHEMBL3342269 |
| Indomethacin | CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | -1.27 | N/A | N/A | 28.57% | CHEMBL518857 |
| Etoricoxib | CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -8.98 | -7.25 | -8.24 | 26.46% | CHEMBL3627862 |
| Indomethacin | CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -8.31 | -6.94 | -7.89 | 39.18% | CHEMBL1644072 |
| Etoricoxib | DRD2_HUMAN | dopamine receptor D2 | -8.80 | N/A | N/A | 38.26% | CHEMBL91463 |
| Indomethacin | DRD2_HUMAN | dopamine receptor D2 | -8.01 | N/A | N/A | 53.99% | CHEMBL245764 |
| Etoricoxib | DRD3_HUMAN | dopamine receptor D3 | -7.85 | N/A | N/A | 36.84% | CHEMBL244773 |
| Indomethacin | DRD3_HUMAN | dopamine receptor D3 | -8.18 | N/A | N/A | 62.43% | CHEMBL461571 |
| Etoricoxib | DRD4_HUMAN | dopamine receptor D4 | -8.89 | -9.07 | N/A | 33.51% | CHEMBL91553 |
| Indomethacin | DRD4_HUMAN | dopamine receptor D4 | -8.83 | -8.63 | N/A | 43.64% | CHEMBL460854 |
| Etoricoxib | EDN1_HUMAN | endothelin 1 | -7.86 | N/A | N/A | N/A | N/A |
| Indomethacin | EDN1_HUMAN | endothelin 1 | -7.02 | N/A | N/A | N/A | N/A |
| Etoricoxib | ESR1_HUMAN | estrogen receptor 1 | -9.12 | -9.58 | -9.43 | 46.46% | CHEMBL371012 |
| Indomethacin | ESR1_HUMAN | estrogen receptor 1 | -6.88 | -8.02 | -8.01 | 62.90% | CHEMBL396118 |
| Etoricoxib | FABP5_HUMAN | fatty acid binding protein 5 | -8.66 | -7.10 | -6.31 | 34.59% | CHEMBL3971182 |
| Indomethacin | FABP5_HUMAN | fatty acid binding protein 5 | -9.13 | -6.06 | -6.31 | 35.86% | CHEMBL3950316 |
| Etoricoxib | FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -9.14 | N/A | N/A | 40.57% | CHEMBL1997822 |
| Indomethacin | FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -8.57 | N/A | N/A | 48.52% | CHEMBL1970352 |
| Etoricoxib | GLRA3_HUMAN | glycine receptor alpha 3 | -8.87 | -9.04 | -8.41 | 20.97% | CHEMBL4070615 |
| Etoricoxib | GLRA3_HUMAN | glycine receptor alpha 3 | -9.20 | N/A | N/A | 20.97% | CHEMBL4070615 |
| Indomethacin | GLRA3_HUMAN | glycine receptor alpha 3 | -8.55 | -8.22 | -8.18 | 27.27% | CHEMBL4070615 |
| Indomethacin | GLRA3_HUMAN | glycine receptor alpha 3 | -9.21 | N/A | N/A | 27.27% | CHEMBL4070615 |
| Etoricoxib | GRM5_HUMAN | glutamate metabotropic receptor 5 | -6.90 | -8.85 | -7.45 | 46.21% | CHEMBL3603921 |
| Indomethacin | GRM5_HUMAN | glutamate metabotropic receptor 5 | -5.57 | -5.30 | -5.48 | 44.03% | CHEMBL377706 |
| Etoricoxib | HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -8.07 | -7.59 | -7.18 | 53.91% | CHEMBL3917928 |
| Indomethacin | HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -7.72 | -6.64 | -6.63 | 34.74% | CHEMBL3425948 |
| Etoricoxib | HRH1_HUMAN | histamine receptor H1 | -7.08 | N/A | N/A | 34.43% | CHEMBL1784685 |
| Indomethacin | HRH1_HUMAN | histamine receptor H1 | -5.94 | N/A | N/A | 50.58% | CHEMBL589389 |
| Etoricoxib | HYES_HUMAN | epoxide hydrolase 2 | -8.37 | -10.09 | -8.61 | 34.64% | CHEMBL567703 |
| Indomethacin | HYES_HUMAN | epoxide hydrolase 2 | -8.11 | -8.74 | -8.18 | 40.59% | CHEMBL3114610 |
| Etoricoxib | IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -9.27 | N/A | N/A | 42.50% | CHEMBL4061406 |
| Indomethacin | IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -8.29 | N/A | N/A | 38.98% | CHEMBL1761510 |
| Etoricoxib | MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -9.00 | -8.50 | N/A | 34.92% | CHEMBL1642 |
| Indomethacin | MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -8.27 | -8.39 | N/A | 47.22% | CHEMBL3354882 |
| Etoricoxib | MIF_HUMAN | macrophage migration inhibitory factor | -6.51 | -7.37 | -6.83 | 30.37% | CHEMBL3906441 |
| Indomethacin | MIF_HUMAN | macrophage migration inhibitory factor | -6.99 | -6.75 | -6.24 | 32.24% | CHEMBL1289631 |
| Etoricoxib | MK01_HUMAN | mitogen-activated protein kinase 1 | -8.04 | -8.01 | -7.63 | 43.79% | CHEMBL3944658 |
| Indomethacin | MK01_HUMAN | mitogen-activated protein kinase 1 | -8.20 | -8.47 | -7.51 | 42.54% | CHEMBL2005528 |
| Etoricoxib | MK03_HUMAN | mitogen-activated protein kinase 3 | -8.30 | -9.06 | -8.33 | 36.99% | CHEMBL1089119 |
| Indomethacin | MK03_HUMAN | mitogen-activated protein kinase 3 | -8.69 | -9.01 | -7.86 | 41.85% | CHEMBL3798015 |
| Etoricoxib | MTOR_HUMAN | mechanistic target of rapamycin kinase | -9.20 | -9.69 | -9.37 | 47.88% | CHEMBL3640942 |
| Indomethacin | MTOR_HUMAN | mechanistic target of rapamycin kinase | -9.04 | -9.56 | -8.97 | 40.38% | CHEMBL1089653 |
| Etoricoxib | NEP_HUMAN | membrane metalloendopeptidase | -8.25 | -6.96 | -8.25 | 25.26% | CHEMBL4085997 |
| Indomethacin | NEP_HUMAN | membrane metalloendopeptidase | -7.48 | -7.58 | -8.41 | 46.11% | CHEMBL305388 |
| Etoricoxib | NK1R_HUMAN | tachykinin receptor 1 | -8.49 | -9.21 | -8.42 | 46.56% | CHEMBL21122 |
| Indomethacin | NK1R_HUMAN | tachykinin receptor 1 | -8.65 | -8.88 | -8.59 | 52.55% | CHEMBL21787 |
| Etoricoxib | NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -7.54 | -9.92 | -8.83 | 21.97% | CHEMBL2333945 |
| Indomethacin | NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -9.03 | -9.52 | -7.00 | 21.43% | CHEMBL284237 |
| Etoricoxib | NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -10.26 | -9.01 | -9.98 | 32.61% | CHEMBL570613 |
| Indomethacin | NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -9.38 | -9.35 | -9.60 | 43.23% | CHEMBL444384 |
| Etoricoxib | NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -9.22 | -10.01 | -8.83 | 30.37% | CHEMBL164322 |
| Indomethacin | NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -8.83 | -9.39 | -7.00 | 38.67% | CHEMBL163916 |
| Etoricoxib | NOS1_HUMAN | nitric oxide synthase 1 | -8.00 | -7.40 | -7.60 | 37.50% | CHEMBL4084332 |
| Indomethacin | NOS1_HUMAN | nitric oxide synthase 1 | -8.92 | -8.92 | -8.81 | 36.41% | CHEMBL474637 |
| Etoricoxib | NOS2_HUMAN | nitric oxide synthase 2 | -7.50 | -8.50 | -8.57 | 34.29% | CHEMBL1800534 |
| Indomethacin | NOS2_HUMAN | nitric oxide synthase 2 | -8.01 | -9.02 | -7.86 | 35.84% | CHEMBL1221659 |
| Etoricoxib | NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -9.77 | -9.90 | -9.99 | 42.22% | CHEMBL2152276 |
| Indomethacin | NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -9.46 | -9.57 | -9.61 | 51.24% | CHEMBL3661550 |
| Etoricoxib | OPRD_HUMAN | opioid receptor delta 1 | -8.26 | -7.60 | -8.08 | 33.16% | CHEMBL2347239 |
| Indomethacin | OPRD_HUMAN | opioid receptor delta 1 | -8.07 | -6.86 | -7.40 | 46.41% | CHEMBL389072 |
| Etoricoxib | OPRK_HUMAN | opioid receptor kappa 1 | -9.69 | -8.94 | -8.47 | 38.07% | CHEMBL1818237 |
| Indomethacin | OPRK_HUMAN | opioid receptor kappa 1 | -9.39 | -8.97 | -7.95 | 50.33% | CHEMBL212574 |
| Etoricoxib | OPRM_MOUSE | Mu-type opioid receptor | -9.05 | -7.71 | N/A | 25.36% | CHEMBL2147903 |
| Indomethacin | OPRM_MOUSE | Mu-type opioid receptor | -8.50 | -8.12 | N/A | 45.83% | CHEMBL2147917 |
| Etoricoxib | OPRX_HUMAN | opioid related nociceptin receptor 1 | -7.79 | -8.12 | -7.33 | 34.43% | CHEMBL1784685 |
| Indomethacin | OPRX_HUMAN | opioid related nociceptin receptor 1 | -7.49 | -7.25 | -7.46 | 50.33% | CHEMBL212574 |
| Etoricoxib | P2RX3_HUMAN | purinergic receptor P2X 3 | -6.06 | -6.10 | -6.31 | 30.41% | CHEMBL3643305 |
| Indomethacin | P2RX3_HUMAN | purinergic receptor P2X 3 | -6.23 | -6.00 | -6.19 | 46.19% | CHEMBL3978296 |
| Etoricoxib | P2Y12_HUMAN | purinergic receptor P2Y12 | -9.98 | -7.71 | -8.05 | 31.00% | CHEMBL3322630 |
| Indomethacin | P2Y12_HUMAN | purinergic receptor P2Y12 | -8.52 | -7.16 | -7.66 | 42.73% | CHEMBL3325895 |
| Etoricoxib | PAR1_HUMAN | coagulation factor II thrombin receptor | -10.14 | N/A | N/A | 40.59% | CHEMBL231942 |
| Indomethacin | PAR1_HUMAN | coagulation factor II thrombin receptor | -6.50 | N/A | N/A | 40.36% | CHEMBL7610 |
| Etoricoxib | PDE4B_HUMAN | phosphodiesterase 4B | -9.54 | -9.64 | -9.65 | 55.88% | CHEMBL1957298 |
| Indomethacin | PDE4B_HUMAN | phosphodiesterase 4B | -9.30 | -9.28 | -9.17 | 43.48% | CHEMBL290191 |
| Etoricoxib | PDE5A_HUMAN | phosphodiesterase 5A | -9.47 | -10.07 | -9.56 | 38.38% | CHEMBL3742354 |
| Indomethacin | PDE5A_HUMAN | phosphodiesterase 5A | -9.11 | -9.95 | -9.38 | 46.00% | CHEMBL245850 |
| Etoricoxib | PERM_HUMAN | myeloperoxidase | -8.48 | -8.66 | -8.34 | 23.08% | CHEMBL2347182 |
| Indomethacin | PERM_HUMAN | myeloperoxidase | -8.42 | -8.77 | -8.79 | 38.99% | CHEMBL2347029 |
| Etoricoxib | PGH1_SHEEP | Prostaglandin G/H synthase 1 | -7.06 | -6.79 | -8.70 | 41.36% | CHEMBL389379 |
| Indomethacin | PGH1_SHEEP | Prostaglandin G/H synthase 1 | -6.52 | -7.10 | -8.65 | 100.00% | CHEMBL6 |
| Etoricoxib | PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | -7.46 | -8.41 | -11.14 | 100.00% | CHEMBL416146 |
| Indomethacin | PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | -4.74 | -5.42 | -7.64 | 100.00% | CHEMBL6 |
| Etoricoxib | PPAP_HUMAN | acid phosphatase 3 | -8.08 | N/A | N/A | 11.04% | CHEMBL453954 |
| Indomethacin | PPAP_HUMAN | acid phosphatase 3 | -8.76 | N/A | N/A | 25.44% | CHEMBL507996 |
| Etoricoxib | PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -8.05 | -9.14 | -8.27 | 41.67% | CHEMBL3695769 |
| Indomethacin | PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -8.28 | -8.72 | -8.41 | 80.00% | CHEMBL360762 |
| Etoricoxib | PRGR_HUMAN | progesterone receptor | -3.45 | -0.80 | -8.28 | 37.50% | CHEMBL3605932 |
| Indomethacin | PRGR_HUMAN | progesterone receptor | -5.84 | -6.69 | -8.93 | 45.21% | CHEMBL3622996 |
| Etoricoxib | PTGES_HUMAN | prostaglandin E synthase | -7.61 | N/A | N/A | 51.09% | CHEMBL585295 |
| Indomethacin | PTGES_HUMAN | prostaglandin E synthase | -6.55 | N/A | N/A | 53.76% | CHEMBL360114 |
| Etoricoxib | SC6A4_HUMAN | solute carrier family 6 member 4 | -9.32 | -9.16 | -8.96 | 36.67% | CHEMBL2419440 |
| Indomethacin | SC6A4_HUMAN | solute carrier family 6 member 4 | -9.36 | -8.74 | -9.19 | 62.43% | CHEMBL461571 |
| Etoricoxib | SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -8.51 | N/A | N/A | 46.11% | CHEMBL3682760 |
| Indomethacin | SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -7.34 | N/A | N/A | 59.52% | CHEMBL3941974 |
| Etoricoxib | TLR4_HUMAN | toll like receptor 4 | -7.97 | -8.33 | -7.72 | 24.57% | CHEMBL3823499 |
| Indomethacin | TLR4_HUMAN | toll like receptor 4 | -7.49 | -7.73 | -7.18 | 38.66% | CHEMBL1223751 |
| Etoricoxib | TNFA_HUMAN | tumor necrosis factor | -7.68 | N/A | N/A | 31.91% | CHEMBL3640372 |
| Indomethacin | TNFA_HUMAN | tumor necrosis factor | -7.50 | N/A | N/A | 46.88% | CHEMBL1392142 |
| Etoricoxib | TRBM_HUMAN | thrombomodulin | -8.45 | -7.31 | N/A | N/A | N/A |
| Indomethacin | TRBM_HUMAN | thrombomodulin | -6.75 | -6.81 | N/A | N/A | N/A |
| Etoricoxib | TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -6.96 | -7.06 | N/A | N/A | N/A |
| Indomethacin | TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -7.51 | -6.53 | N/A | N/A | N/A |
| Etoricoxib | TRPM8_FICAL | Uncharacterized protein | -9.56 | N/A | N/A | N/A | N/A |
| Indomethacin | TRPM8_FICAL | Uncharacterized protein | -9.14 | N/A | N/A | N/A | N/A |
| Etoricoxib | TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -7.22 | N/A | N/A | 40.26% | CHEMBL276153 |
| Indomethacin | TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -7.32 | N/A | N/A | 50.53% | CHEMBL438345 |
| Etoricoxib | TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -7.46 | -6.89 | N/A | N/A | N/A |
| Indomethacin | TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -8.17 | -7.86 | N/A | N/A | N/A |
| Etoricoxib | TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -7.19 | -8.16 | N/A | 47.27% | CHEMBL3692319 |
| Indomethacin | TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -6.80 | -6.76 | N/A | 35.94% | CHEMBL3664218 |
| Etoricoxib | TRXR1_HUMAN | thioredoxin reductase 1 | -7.95 | -7.52 | -7.05 | N/A | N/A |
| Indomethacin | TRXR1_HUMAN | thioredoxin reductase 1 | -8.00 | -7.70 | -6.46 | N/A | N/A |
| Etoricoxib | TRY1_HUMAN | serine protease 1 | -7.28 | N/A | N/A | 38.36% | CHEMBL92883 |
| Indomethacin | TRY1_HUMAN | serine protease 1 | -6.06 | N/A | N/A | 52.02% | CHEMBL422722 |